Targeting therapeutic nanoparticles to the glioblastoma resection margin by harnessing postoperative blood-brain barrier disruption | Science Translational Medicine
A transient, postoperative window of blood-brain barrier permeability enables repurposing of clinically used liposomal nanoparticles for glioblastoma.
